射血分数
心力衰竭
医学
心脏病学
内科学
利钠肽
作者
Biykem Bozkurt,Andrew J.S. Coats,Hiroyuki Tsutsui,Magdy Abdelhamid,Stamatis Adamopoulos,Nancy M. Albert,Stefan D. Anker,J. Atherton,Michael Böhm,Javed Butler,Mark H. Drazner,G. Michael Felker,Gerasimos Filippatos,Mona Fiuzat,Gregg C. Fonarow,Juan‐Esteban Gomez‐Mesa,Paul A. Heidenreich,Teruhiko Imamura,Ewa A. Jankowska,James L. Januzzi
摘要
Abstract In this document, we propose a universal definition of heart failure (HF) as a clinical syndrome with symptoms and/or signs caused by a structural and/or functional cardiac abnormality and corroborated by elevated natriuretic peptide levels and/or objective evidence of pulmonary or systemic congestion. We also propose revised stages of HF as: At risk for HF (Stage A), Pre‐HF (Stage B), Symptomatic HF (Stage C) and Advanced HF (Stage D). Finally, we propose a new and revised classification of HF according to left ventricular ejection fraction (LVEF). This includes HF with reduced ejection fraction (HFrEF): symptomatic HF with LVEF ≤40%; HF with mildly reduced ejection fraction (HFmrEF): symptomatic HF with LVEF 41–49%; HF with preserved ejection fraction (HFpEF): symptomatic HF with LVEF ≥50%; and HF with improved ejection fraction (HFimpEF): symptomatic HF with a baseline LVEF ≤40%, a ≥10 point increase from baseline LVEF, and a second measurement of LVEF > 40%.
科研通智能强力驱动
Strongly Powered by AbleSci AI